Liposomal forms of doxorubicin and cisplatin in phase I trials.
D002945:Cisplatin / Q000008:administration & dosage* / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D004337:Drug Carriers; D004341:Drug Evaluation; D006801:Humans; D008081:Liposomes; D009369:Neoplasms / Q000188:drug therapy
D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin; D002945:Cisplatin